NEU neuren pharmaceuticals limited

Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-30

  1. 721 Posts.
    lightbulb Created with Sketch. 405

    ok, then I misunderstood and I apologise, in my opinion rather than appreciating the progress of competitors they appreciate the updating of the competition, being always up to date also helps to evaluate our investment, I'm speaking as a cynical shareholder who thinks of earning money, if instead we look at this update in a more ethical way. We welcome the progress of the competitors, people involved in the various syndromes also read here and it is right that sooner or later treatments will be found, obviously hoping that our nnz-2591 jewel is the best of everyone !!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.55 235 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.